Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]
News [4199]
Articles [376]
Editorials [10]
Conferences [105]
elearning [29]
MyPathway study: a novel precision oncology multiple basket trial
Dr Mary S. Beattie - Genentech, USA
MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )
6 Jul 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018
CDK6 a transcriptional regulator in AML
Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna...
CDK6 a transcriptional regulator in AML ( Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna, Austria )
27 Jun 2018
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )
24 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018
Design and interim safety analysis of GeparX trial
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018
What does progression-free survival mean for breast cancer patients?
Dr Peter Schmid - Barts Cancer Institute, London, UK
What does progression-free survival mean for breast cancer patients? ( Dr Peter Schmid - Barts Cancer Institute, London, UK )
4 Jun 2018
Finding appropriate doses for HER2 positive breast cancers
Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA
Finding appropriate doses for HER2 positive breast cancers ( Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA )
3 Jun 2018
Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast...
Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany
Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast cancer ( Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany )
3 Jun 2018
Most breast cancer patients could avoid chemo with use of genetic testing
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Most breast cancer patients could avoid chemo with use of genetic testing ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
Comment: Genetic testing of early breast tumours could allow patients to go...
Dr Harold Burstein & Prof Richard Schilsky
Comment: Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Harold Burstein & Prof Richard Schilsky )
3 Jun 2018
Genetic testing of early breast tumours could allow patients to go without chemo
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation